The role of targeted therapy in ovarian cancer

Abstract Ovarian cancer is the second most common gynaecological malignancy and the leading cause of death from gynaecological cancer. Although in some cases treatment is initially effective, there is a considerable risk of disease recurrence and resistance to therapy. Therapies targeting molecular...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of cancer (1990) 2011-09, Vol.47, p.S116-S130
Hauptverfasser:	Banerjee, Susana, Kaye, Stan
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Carcinoma - blood supply Carcinoma - therapy Clinical Trials, Phase I as Topic - methods Clinical Trials, Phase II as Topic - methods Female Hematology, Oncology and Palliative Medicine Humans Models, Biological Molecular Targeted Therapy - methods Molecular Targeted Therapy - utilization Ovarian Neoplasms - blood supply Ovarian Neoplasms - therapy Vascular Endothelial Growth Factor A - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!